Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Using Treg, Tr1, and Breg Expression Levels to Predict Clinical Responses to csDMARD Treatment in Drug-naive Patients With Rheumatoid Arthritis

Published:2023 Issue:5 Volume:37 Page:2018-2027
ISSN:0258-851X
Container-title:In Vivo
language:en
Short-container-title:In Vivo

Author:

HSIEH TING-YU,LUI SHAN-WEN,LU JENG-WEI,CHEN YEN-CHEN,LIN TING-CHUN,JHENG WUN-LONG,HO YI-JUNG,LIU FENG-CHENG

Publisher

Anticancer Research USA Inc.

Subject

Pharmacology,General Biochemistry, Genetics and Molecular Biology,Cancer Research

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of DNMT1 attenuates experimental food allergy;Molecular Immunology;2024-09

2. TRIM41 contributes to the pathogenesis of airway allergy by compromising dendritic cells’ tolerogenic properties;iScience;2024-06

3. Causal Association Between Peripheral blood immune cells and Rheumatoid Arthritis: A Bidirectional Mendelian Randomization Study;2024-02-02

4. Functional implications of rs9373441 with FOXP3+Treg and Tr1 for the clinical effectiveness of csDMARDs in rheumatoid arthritis;Clinica Chimica Acta;2023-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP